Ocular Therapeutix (OCUL) Treasury Shares (2013 - 2025)

Ocular Therapeutix's Treasury Shares history runs 6 years deep, the most recent figure standing at $1.5 million for Q4 2025.

• On a quarterly basis, Treasury Shares fell 55.75% year-over-year to $1.5 million in Q4 2025; TTM through Dec 2025 was $1.5 million, a 55.75% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, up 28.61% from the prior year.
• Treasury Shares fell to $1.5 million in Q4 2025 per OCUL's latest filing, from $3.4 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.4 million in Q4 2024 and bottomed at $1.1 million in Q4 2022.
• The 4-year median for Treasury Shares is $1.6 million (2023), against an average of $1.9 million.
• Across the five-year window, Treasury Shares jumped 108.29% in 2024 and slumped 55.75% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $1.1 million in 2022, then soared by 48.93% to $1.6 million in 2023, then soared by 108.29% to $3.4 million in 2024, then slumped by 55.75% to $1.5 million in 2025.
• Per Business Quant, the three latest OCUL Treasury Shares figures stand at $1.5 million (Q4 2025), $3.4 million (Q4 2024), and $1.6 million (Q4 2023).